发明名称 Composition for treating cardiovascular disease, diabetes, cancer, Alzheimer's disease, has tannase-producing strains of Lactobacillus plantarum or Lactobacillus species that adhere to human intestinal mucosa in combination with tannin
摘要 A composition (I), comprises one or more tannase-producing strains of Lactobacillus plantarum or closely related Lactobacillus species having the ability to adhere to human intestinal mucosa in combination with tannin. An independent claim is also included for a tannase-producing strain (II) of L.plantarum or a closely related Lactobacillus species having the ability to adhere to the human intestinal mucosa, with tannase activity as determined by Osawa and Walsh, excluding the strains L.plantarum 299, DSM 6595, and L.plantarum 299v, DSM 9843. ACTIVITY : Cardiovascular-Gen.; Antidiabetic; Antiinflammatory; Gastrointestinal-Gen.; Cytostatic; Neuroprotective; Nootropic; Immunosuppressive. No supporting data is given. MECHANISM OF ACTION : None given.
申请公布号 SE527555(C2) 申请公布日期 2006.04.11
申请号 SE20030000994 申请日期 2003.04.04
申请人 PROBI AB 发明人 GOERAN MOLIN;SIV AHRNE;BENGT JEPPSSON
分类号 C12N1/20;A23L1/30;A61K;A61K31/35;A61K31/7032;A61K35/74;A61P1/00;A61P3/00;A61P9/00 主分类号 C12N1/20
代理机构 代理人
主权项
地址